EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Relationship between neutrophil-lymphocyte ratio and platelet-lymphocyte ratio with the severity of COVID-19

Ida A Arini, Sri Masyeni, Ni W Widhidewi

Narra J · 2024

DOI: 10.52225/narra.v4i1.262 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Narra J, 2024. Verfasst von Ida A Arini und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Sciences, Universitas Warmadewa, Denpasar, Indonesia. Hauptthemen laut MEDLINE: COVID-19, Neutrophils, Severity of Illness Index, Lymphocytes. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronavirus disease 2019 (COVID-19) is an infectious disease that spreads rapidly causing a high case fatality rate in vulnerable populations. Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) are known to be inflammatory biomarkers in certain infections. The aim of this study was to determine the relationship between NLR and PLR with the severity of COVID-19. A cross-sectional study was conducted at Tabanan Regency General Hospital, Bali, Indonesia, from January 2021 to December 2022. All patients included in the study tested positive for COVID-19 by real-time polymerase chain reaction (RT-PCR), aged 18–50 years with no comorbid. Laboratory examinations were carried out on admission. The patients were categorized into two groups based on the severity: moderate and severe/critical. The Mann-Whitney test was used to determine the association between NLR and PLR with the severity of COVID-19. A total of 104 patients were included in the study, the majority of COVID-19 patients had moderate (77.9%) severity. The average NLR was 5.8 and the PLR was 21.7. There was a significant relationship between NLR (p=0.002) and PLR (p=0.001) with the severity of COVID-19. The defined cut-off values of NLR and PLR were ≥3.8 and ≥106, yielding sensitivities of 95% and 70%, and specificities of 74% and 50%, respectively. This study highlights the promising role of NLR and PLR as predictive biomarkers to assess COVID-19 severity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19NeutrophilsSeverity of Illness IndexLymphocytesHumansMaleFemaleCross-Sectional StudiesMiddle AgedAdultIndonesiaLymphocyte CountPlatelet CountBlood PlateletsBiomarkersAdolescentSARS-CoV-2Young Adult

Stichwörter der Autor:innen

BaliCOVID-19COVID-19 severityNLRPLR

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Faculty of Medicine and Health Sciences, Universitas Warmadewa, Denpasar, Indonesia.
  • Department of Internal Medicine, Faculty of Medicine and Health Sciences, Universitas Warmadewa, Denpasar, Indonesia.
  • Department of Microbiology and Parasitology, Faculty of Medicine and Health Sciences, Universitas Warmadewa, Denpasar, Indonesia.

Zitieren

APA

Arini, I. A., Masyeni, S., & Widhidewi, N. W. (2024). Relationship between neutrophil-lymphocyte ratio and platelet-lymphocyte ratio with the severity of COVID-19. Narra J. https://doi.org/10.52225/narra.v4i1.262

Vancouver

Arini IA, Masyeni S, Widhidewi NW. Relationship between neutrophil-lymphocyte ratio and platelet-lymphocyte ratio with the severity of COVID-19. Narra J. 2024. doi:10.52225/narra.v4i1.262

BibTeX
@article{Arini2024,
  author = {Arini, Ida A and Masyeni, Sri and Widhidewi, Ni W},
  title = {Relationship between neutrophil-lymphocyte ratio and platelet-lymphocyte ratio with the severity of COVID-19},
  journal = {Narra J},
  year = {2024},
  doi = {10.52225/narra.v4i1.262}
}
Kostenlos starten →